HVIVO PLC LS-,001

No trades
See on Supercharts
Market capitalization
129.684MEUR
Dividends yield (FY)
Price to earnings Ratio (TTM)
Basic EPS (TTM)
−0.001EUR

About HVIVO PLC LS-,001

CEO
Yamin Mohammed Khan
Headquarters
London
Founded
2011
ISIN
GB00B9275X97

hVIVO PLC provides pharmaceutical development services. The company operates under the hVIVO and Venn Life Sciences Clinical Division. The hVIVO segment is involved in the conducting of human challenge trials and related laboratory services. The Venn Life Sciences Clinical Research Division provides consulting and clinical trial services to pharmaceutical, biotechnology, and medical device organizations. The company was founded on February 1, 2011 and is headquartered in London, the United Kingdom.

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Be warned
Past performance
Revenue to profit conversion
Total revenue
Gross profit
EBITDA
EBIT
Net income
‪0%‬
‪0%‬
‪0%‬
‪0%‬
‪0%‬
Debt level and coverage
Earnings
Next:
‪0‬
OANDA
Forex
4.52Great
FOREX.com
4.38Fabulous
Interactive Brokers
Stocks, Futures, Bonds
4.35Fabulous

See all brokers 

Gain new superpowers

Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world.Learn more